ministry of health - nationale medication agency

8/9/2019 Ministry of Health - Nationale Medication Agency

1/12

Project

’médicament [National

e ca on gency

NEW YORK FORUM AFRICA 2012 – OBJECTIVES 2016 – HORIZON 2025


2/12

,

facilities in

terms

of

medicines

and

medical

ev ces are not a equate y met.

The issue of access to medication has led us

to seek

‘public

‐private’

partnerships

with

a

view to rovidin the ualit and uantit of

medical coverage needed across the country.


3/12

1. The context of the project

2. The ob ectives of the Medication A enc

3. The strengths of the project

.

5. The expected effects

.

7. The timetable (for information)


4/12

.In Gabon, 3 structures are dedicated to bundle

–

billion CFA Francs – clientele: pharmacies and private

healthcare facilities

COPHARGA: private organisation – turnover of 17 billion

CFA Frances – Clientele: harmacies and rivate healthcare

facilities

ce armaceu que a ona a ona

Pharmaceutical Office] – industrial and commercial public

institution – Bud et of 2.4 billion CFA Francs – Clientele:

public healthcare facilities (645)


5/12

.In contrast to the other purchasing groups of ACAME

the OPN is still unable to meet national needs from the point

of view of its operational standards.

The main findings show:

An insufficient bud et estimated re uired bud et: 8 billion

CFA Francs)

Poor stock management

A random and unsecured transport system

Inefficient financial management (collection) An incomplete range of medicines


6/12

.

Creating a new purchasing group with the aim of:

Offerin a much wider ran e of medicines

Optimising stock management using a dedicated software

application and setting up networks of user structures

Optimising and securing storage, transportation anddistribution of medicines in order to ensure traceability

p m s ng nanc a managemen , nc u ng a mo ern

financial service, and implementing a satisfactory payment

collection s stem


7/12

.

3.1 Meeting the needs of the Gabonese population in

terms of medicines and medical devices would costan estimated 76 billion CFA Francs

3.2 Given the context and the turnover of privatepurchasing groups, a contract is on offer, through

w c t e gency cou recover o t e turnover

and the Gabonese government would grant tax

.


8/12

.3.3 Advantages of establishing the Medication Agency in

Gabon:

Gabon, as a non-landlocked country, is a real hub due its, , .

has easy access to ports and airports, making sub-

re ional activit a ossibilit .

From a political point of view, Gabon is widely recognised asstable.

From a customs perspective, medicines and medical

devices are wholly tax exempt.

e coun ry ene s rom a we - eve ope an ng sys em

with currency transfer facilities.

the Gabonese population.


9/12

.for information

y : u ‐ v

To be set up on agreed terms.


10/12

.

Financial impact

Political impact

Healthy population = economic driver Healthy population = social cohesion

Social and economic impact

leading to a decrease in morbidity and mortality rates


11/12

.for information

6.1 Projected operating accounts

6.2 Forecast balance sheets


12/12

.for information

Description of all the project’s activities with timeframes

ministry of health - nationale medication agency

Documents